ReviewCurrent organic synthesis2026
Synthetic Progress and Antifungal Potential of Thiophene Chalcone Derivatives: A Review.
Review in Current organic synthesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal infections constitute a major global health concern, with annual mortality rates exceeding those of tuberculosis and malaria. This troubling situation has been exacerbated by the emergence of multidrug-resistant fungal strains, which have significantly undermined the effectiveness of current treatments. A number of antifungal medicines are now being utilised in clinical practice. Some of these treatments include azoles, polyenes, pyrimidines, and echinocandins. However, the therapeutic efficacy of these drugs is becoming increasingly limited due to the presence of unwanted side effects, drug-drug interactions, and the rapid development of resistant fungal strains. This growing concern underscores the urgent need for novel antifungal drugs that are safer and more effective than those currently available. Chalcone compounds, whether they are natural or synthetic, have demonstrated significant pharmacological potential due to their extensive range of biological activities. This can be mostly related to the presence of the reactive α, β-unsaturated carbonyl group that is characteristic of chalcones. Furthermore, thiophene is an important scaffold in medicinal chemistry owing to its diverse biological applications. This review article is structured into two main parts. The first part provides an overview of the synthesis of thiophene chalcone derivatives using conventional methods via the Claisen-Schmidt condensation reaction, highlighting the reaction conditions, catalysts, solvent systems, time, and reported yields from recent studies. The second part presents a summary of thiophene chalcone derivatives evaluated over the past decade (2015-2025) for their antifungal properties, discussing the assays performed, fungal strains tested, and the overall biological outcomes reported.
Indexed as
Identifiers
42003116What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.